| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVAX | NOVAVAX INC | Kelly James Patrick | EVP, CFO and Treasurer | Mar 10, 2024 | Option Exercise | $5.45 | 2,226 | 12,132 | 13,285 | Mar 12, 2024, 08:46 PM | |
| NVAX | NOVAVAX INC | Kelly James Patrick | EVP, CFO and Treasurer | Mar 07, 2024 | Option Exercise | $5.61 | 5,905 | 33,127 | 10,903 | Mar 11, 2024, 09:39 PM | |
| NVAX | NOVAVAX INC | Kelly James Patrick | EVP, CFO and Treasurer | Aug 16, 2023 | Option Exercise | $7.13 | 1,143 | 8,150 | 4,584 | Aug 18, 2023, 04:37 PM | |
| NVAX | NOVAVAX INC | Kelly James Patrick | EVP, CFO and Treasurer | Mar 10, 2023 | Option Exercise | $6.52 | 7,080 | 46,162 | 5,832 | Mar 14, 2023, 05:19 PM | |
| NVAX | NOVAVAX INC | Kelly James Patrick | EVP, CFO and Treasurer | Aug 16, 2022 | Option Exercise | $42.88 | 1,144 | 49,055 | 1,223 | Aug 18, 2022, 05:02 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | EVP & Chief Financial Officer | Mar 02, 2020 | Sale | $10.19 | 12,968 | 132,087 | 192,758 | Mar 04, 2020, 05:01 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | EVP & Chief Financial Officer | Mar 03, 2020 | Sale | $10.76 | 5,889 | 63,359 | 186,869 | Mar 04, 2020, 05:01 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | EVP & Chief Financial Officer | Jan 02, 2020 | Sale | $15.94 | 4,020 | 64,086 | 205,726 | Jan 06, 2020, 05:25 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | EVP & Chief Financial Officer | Mar 01, 2019 | Sale | $20.15 | 4,976 | 100,271 | 218,497 | Mar 04, 2019, 05:06 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | EVP & Chief Financial Officer | Mar 04, 2019 | Sale | $19.88 | 8,751 | 173,961 | 209,746 | Mar 04, 2019, 05:06 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | EVP & Chief Financial Officer | Jan 02, 2019 | Sale | $26.47 | 4,442 | 117,579 | 196,221 | Jan 04, 2019, 04:33 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | EVP & Chief Financial Officer | Jan 03, 2019 | Sale | $26.08 | 1,619 | 42,232 | 193,473 | Jan 04, 2019, 04:33 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | EVP & Chief Financial Officer | Mar 01, 2018 | Sale | $18.72 | 8,532 | 159,712 | 199,534 | Mar 02, 2018, 05:34 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | EVP & Chief Financial Officer | Jan 02, 2018 | Sale | $15.35 | 9,155 | 140,494 | 168,066 | Jan 04, 2018, 05:12 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | SVP, CFO & Treasurer | Jan 03, 2017 | Sale | $15.51 | 10,895 | 169,013 | 69,721 | Jan 05, 2017, 05:01 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | SVP, CFO, Sec & Treasurer | Jan 04, 2016 | Sale | $8.96 | 9,564 | 85,693 | 60,772 | Jan 06, 2016, 07:09 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | SVP, CFO, Sec & Treasurer | Mar 10, 2015 | Sale | $10.53 | 12,450 | 131,098 | 53,304 | Mar 12, 2015, 06:53 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | SVP, CFO, Sec & Treasurer | Nov 19, 2013 | Sale | $12.07 | 3,348 | 40,421 | 28,816 | Nov 21, 2013, 08:00 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | SVP, CFO, Sec & Treasurer | Feb 14, 2013 | Option Exercise | $3.95 | 6,978 | 27,563 | 22,789 | Feb 19, 2013, 08:38 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | SVP, CFO, Sec & Treasurer | Feb 16, 2012 | Sale | $4.67 | 4,920 | 22,994 | 12,580 | Feb 21, 2012, 06:00 PM | |
| VNDA | Vanda Pharmaceuticals Inc. | Kelly James Patrick | SVP, CFO, Sec & Treasurer | Aug 29, 2011 | Buy | $5.99 | 5,000 | 29,952 | 5,000 | Aug 30, 2011, 04:31 PM |
Menu